Mr. Simes has been Vice Chairman, President & CEO of BioSante Pharmaceuticals, Inc. since January 1998.

BS in Chemistry from Brooklyn College of the City University of New York MBA from New York University.

President & CEO
BioSante Pharmaceuticals, Inc.

Mr. Simes has been Vice Chairman, President & CEO of BioSante Pharmaceuticals, Inc. since January 1998.

Prior to BioSante, Mr. Simes was President & CEO of Unimed Pharmaceuticals, Inc. and Gynex Pharmaceuticals, Inc., both of which were sold to bigger companies; Unimed to Solvay and Gynex to Bio-Technology General Corp. (now Savient Pharmaceuticals, Inc.)

Mr. Simes started his career in the pharmaceutical industry with G.D. Searle & Co. in 1974.

Since 1984, Mr. Simes has specialized in emerging companies, building product portfolios in endocrinology, urology, hormones and drug delivery systems, among other areas.

Mr. Simes holds a BS in Chemistry from Brooklyn College of the City University of New York and an MBA from New York University.

Nanotechnology is yet another way for us to improve the human condition. With appropriate development in its many applications benefits will become more apparant. In the case of BioSante, we are hopeful we can help develop safer and more effective vaccines and oral drugs where injectible ones are used now.